Description
The CJC-1295 No DAC / Ipamorelin blend is one of the most widely researched peptide combinations in the field of growth hormone secretagogues (GHSs). By working together, these two peptides stimulate the natural release of growth hormone (GH) from the pituitary gland, promoting benefits such as improved recovery, lean muscle development, fat reduction, and better sleep quality.
This article explores what the CJC-1295 No DAC / Ipamorelin blend is, how it works, its benefits, dosage protocols, potential side effects, and safety considerations.
What is the CJC-1295 No DAC / Ipamorelin Blend?
The blend combines two synergistic peptides:
-
CJC-1295 No DAC (Without Drug Affinity Complex):
-
A growth hormone-releasing hormone (GHRH) analog.
-
Short-acting version that mimics the body’s natural pulsatile GH release.
-
-
Ipamorelin:
-
A growth hormone-releasing peptide (GHRP).
-
Selectively stimulates GH release without significantly increasing cortisol or prolactin.
-
Together: This blend enhances natural GH secretion, leading to improved body composition, recovery, and anti-aging effects.
How Does It Work?
-
CJC-1295 No DAC binds to GHRH receptors, increasing pituitary GH release.
-
Ipamorelin activates ghrelin receptors (GHS-R), triggering additional GH release.
-
Combined Effect: Greater and more sustained GH pulses, which lead to increased IGF-1 levels, driving muscle growth, fat metabolism, and tissue repair.
Benefits
-
Muscle Growth and Recovery
-
Enhances protein synthesis and lean muscle development.
-
Supports faster recovery from training and injuries.
-
-
Fat Loss
-
Promotes lipolysis (fat breakdown).
-
Improves body composition by reducing fat mass.
-
-
Anti-Aging Properties
-
Boosts collagen production for healthier skin and joints.
-
Supports bone density and overall vitality.
-
-
Improved Sleep Quality
-
Enhances deep REM sleep, contributing to recovery and hormone balance.
-
-
Metabolic and Immune Support
-
Regulates glucose metabolism.
-
May strengthen immune system function.
-
Dosage and Administration
⚠️ Research use only – not FDA-approved for general medical use.
-
CJC-1295 No DAC Dosage: Common research protocols use 100–200 mcg per injection, typically 1–3 times daily.
-
Ipamorelin Dosage: Often matched with CJC-1295 at 100–200 mcg per injection.
-
Administration: Subcutaneous injection (under the skin).
-
Timing: Best taken before bed or post-workout to maximize natural GH release cycles.
Reviews
There are no reviews yet.